Actinium Pharmaceuticals, Inc. (ATNM)

1.41 +0.01 (+0.71%) USD  |  NYAM  |  Dec 09, 15:46
More

Actinium Pharmaceuticals EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for ATNM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
Arcus Biosciences, Inc. Upgrade
Apyx Medical Corp. Upgrade
AbbVie, Inc. Upgrade
Karyopharm Therapeutics, Inc. Upgrade
NovaBay Pharmaceuticals, Inc. Upgrade